C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 295/26 (2006.01) A61K 31/40 (2006.01) A61K 31/454 (2006.01) A61K 31/495 (2006.01) A61K 31/551 (2006.01) A61P 29/00 (2006.01) A61P 37/00 (2006.01) C07D 207/48 (2006.01) C07D 211/96 (2006.01) C07D 401/04 (2006.01) C07D 403/04 (2006.01) C07D 403/06 (2006.01) C07D 471/04 (2006.01)
Patent
CA 2459432
The present invention relates to a sulfonamide derivative which is useful as an active ingredient of pharmaceutical preparations. The sulfonamide derivatives of the present invention have CCR3 (CC type chemokine receptor) antagonistic activity, and can be used for the prophylaxis and treatment of diseases associated with CCR3 activity, in particular for the treatment of asthma, atopic dermatitis, allergic rhinitis and other inflammatory/immunological disorders.
L'invention concerne un dérivé de sulfonamide utile comme principe actif de préparations pharmaceutiques. Les dérivés de sulfonamide de l'invention présentent une activité antagoniste de CCR3 (récepteur de chimiokines du type CC), et peuvent être utilisés pour prévenir ou traiter des maladies associées à l'activité de CCR3, notamment l'asthme, la dermatite atopique, la rhinite allergique et d'autres affections inflammatoires/immunitaires.
Bacon Kevin
Fukushima Keiko
Kawamura Norihiro
Kikuchi Tetsuo
Li Yingfu
Axikin Pharmaceuticals Inc.
Bayer Healthcare Ag
Fetherstonhaugh & Co.
LandOfFree
Arylsulfonamide derivatives for use as ccr3 antagonists in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Arylsulfonamide derivatives for use as ccr3 antagonists in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylsulfonamide derivatives for use as ccr3 antagonists in... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1793473